Categories
Biopharmaceutical
About Us
On May 18, 2016, we opened a 43,000-square-foot Foundational Neuroscience Center (FNC) in Cambridge, Massachusetts. At the FNC, we will undergo research to gain a deeper understanding of the biological mechanisms underlying neurodegenerative diseases. Our goal is to identify novel therapeutic approaches for bringing relief to our patients living with these chronic, debilitating diseases.We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
